DRG is engaged in offering high-value data, analytics and insights products and services to the healthcare industry.
The deal includes $900m in cash, as well as issuing of up to $50m in Clarivate ordinary shares following the first anniversary of closing.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,